Cellenkos

Houston, United States

Cellenkos is a clinical stage biotech company.

$15.0M raised

Nov 2021

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cellenkos raised?

Cellenkos has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.

Who are Cellenkos's investors?

Cellenkos's investors include BVCF.

Where is Cellenkos headquartered?

Cellenkos is headquartered in Houston, United States.

What does Cellenkos do?

Cellenkos is a clinical stage biotech company.

What stage is Cellenkos at?

Cellenkos is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 4, 2021.

MLA

"Cellenkos — Funding & Investors." VCBacked, November 4, 2021, https://www.vcbacked.co/company/cellenkos. Accessed July 3, 2026.

APA

VCBacked. (2021). Cellenkos — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/cellenkos

Wikipedia (cite web)

{{cite web |title=Cellenkos — Funding & Investors |url=https://www.vcbacked.co/company/cellenkos |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 4, 2021.